Cargando…

Plasma GFAP associates with secondary Alzheimer's pathology in Lewy body disease

OBJECTIVE: Within Lewy body spectrum disorders (LBSD) with α‐synuclein pathology (αSyn), concomitant Alzheimer's disease (AD) pathology is common and is predictive of clinical outcomes, including cognitive impairment and decline. Plasma phosphorylated tau 181 (p‐tau(181)) is sensitive to AD neu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cousins, Katheryn A. Q., Irwin, David J., Chen‐Plotkin, Alice, Shaw, Leslie M., Arezoumandan, Sanaz, Lee, Edward B., Wolk, David A., Weintraub, Daniel, Spindler, Meredith, Deik, Andres, Grossman, Murray, Tropea, Thomas F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10187730/ https://www.ncbi.nlm.nih.gov/pubmed/37000892 http://dx.doi.org/10.1002/acn3.51768

Ejemplares similares

Tau pathology associates with in vivo cortical thinning in Lewy body disorders
por: Spotorno, Nicola, et al.
Publicado: (2020)

Plasma phosphorylated tau181 predicts cognitive and functional decline
por: Tropea, Thomas F., et al.
Publicado: (2022)

Signature laminar distributions of pathology in frontotemporal lobar degeneration
por: Ohm, Daniel T., et al.
Publicado: (2022)

Narrative Organization Deficit in Lewy Body Disorders Is Related to Alzheimer Pathology
por: Grossman, Murray, et al.
Publicado: (2017)

CSF proteome profiling reveals biomarkers to discriminate dementia with Lewy bodies from Alzheimer´s disease
por: del Campo, Marta, et al.
Publicado: (2023)

Decision-Making Deficits Associated with Amyloidosis in Lewy Body Disorders
por: Spotorno, Nicola, et al.
Publicado: (2017)

Hereditary Myoclonus Dystonia: A Novel SGCE Variant and Phenotype Including Intellectual Disability
por: Coughlin, David G., et al.
Publicado: (2018)

Clinical Correlates of Alzheimer's Disease Cerebrospinal Fluid Analytes in Primary Progressive Aphasia
por: Norise, Catherine, et al.
Publicado: (2019)

Elevated CSF GAP-43 is Alzheimer’s disease specific and associated with tau and amyloid pathology
por: Sandelius, Åsa, et al.
Publicado: (2018)

Circulating brain-enriched microRNAs as novel biomarkers for detection and differentiation of neurodegenerative diseases
por: Sheinerman, Kira S., et al.
Publicado: (2017)

Longitudinal Changes in Semantic Concreteness in Semantic Variant Primary Progressive Aphasia (svPPA)
por: Cousins, Katheryn A. Q., et al.
Publicado: (2018)

Comparison of category and letter fluency tasks through automated analysis
por: Gonzalez-Recober, Carmen, et al.
Publicado: (2023)

Quantitative detection of α-Synuclein and Tau oligomers and other aggregates by digital single particle counting
por: Blömeke, Lara, et al.
Publicado: (2022)

Lateralized ante mortem and post mortem pathology in a case of Lewy body disease with corticobasal syndrome
por: Coughlin, David G., et al.
Publicado: (2022)

Cerebrospinal fluid neurogranin concentration in neurodegeneration: relation to clinical phenotypes and neuropathology
por: Portelius, Erik, et al.
Publicado: (2018)

Are Parkinson’s Disease Patients the Ideal Preclinical Population for Alzheimer’s Disease Therapeutics?
por: Tropea, Thomas F., et al.
Publicado: (2021)

GFAP at 50
por: Messing, Albee, et al.
Publicado: (2020)

Cerebrospinal fluid biomarkers for differentiation of frontotemporal lobar degeneration from Alzheimer's disease
por: Irwin, David J., et al.
Publicado: (2013)

Evaluation of an educational conference for persons affected by hereditary frontotemporal degeneration and amyotrophic lateral sclerosis
por: Dratch, Laynie, et al.
Publicado: (2022)

Longitudinal naming and repetition relates to AD pathology and burden in autopsy‐confirmed primary progressive aphasia
por: Cousins, Katheryn A.Q., et al.
Publicado: (2021)

Automated Analysis of Digitized Letter Fluency Data
por: Cho, Sunghye, et al.
Publicado: (2021)

Regulation of GFAP Expression
por: Brenner, Michael, et al.
Publicado: (2021)

Caffeine Consumption and Dementia: Are Lewy Bodies the Link?
por: Cornelis, Marilyn C., et al.
Publicado: (2022)

An Alzheimer’s Disease-Derived Biomarker Signature Identifies Parkinson’s Disease Patients with Dementia
por: Berlyand, Yosef, et al.
Publicado: (2016)

CSF and Blood Levels of GFAP in Alexander Disease
por: Jany, Paige L., et al.
Publicado: (2015)

GFAP expression in injured astrocytes in rats
por: Zhang, Shuquan, et al.
Publicado: (2017)

Serological biomarkers in autoimmune GFAP astrocytopathy
por: Fu, Cong-Cong, et al.
Publicado: (2022)

Isolation and characterization of GFAP-positive porcine neural stem/progenitor cells derived from a GFAP-CreER(T2) transgenic piglet
por: Kim, Eunhye, et al.
Publicado: (2018)

GFAPδ/GFAPα ratio directs astrocytoma gene expression towards a more malignant profile
por: Stassen, Oscar M.J.A., et al.
Publicado: (2017)

Apraxia of Speech in the Spontaneous Speech of Nonfluent/Agrammatic Primary Progressive Aphasia
por: Ash, Sharon, et al.
Publicado: (2023)

Neural Correlates of Verbal Episodic Memory and Lexical Retrieval in Logopenic Variant Primary Progressive Aphasia
por: Win, Khaing T., et al.
Publicado: (2017)

Genetic prediction of impulse control disorders in Parkinson's disease
por: Weintraub, Daniel, et al.
Publicado: (2022)

Beneficial Effect of Phenytoin and Carbamazepine on GFAP Gene Expression and Mutant GFAP Folding in a Cellular Model of Alexander’s Disease
por: Bachetti, Tiziana, et al.
Publicado: (2021)

Plasma GFAP is an early marker of amyloid-β but not tau pathology in Alzheimer’s disease
por: Pereira, Joana B, et al.
Publicado: (2021)

Multimarker synaptic protein cerebrospinal fluid panels reflect TDP-43 pathology and cognitive performance in a pathological cohort of frontotemporal lobar degeneration
por: Cervantes González, Alba, et al.
Publicado: (2022)

Tau immunotherapy is associated with glial responses in FTLD-tau
por: Kim, Boram, et al.
Publicado: (2021)

Encephalitis with radial perivascular emphasis: Not necessarily associated with GFAP antibodies
por: Wickel, Jonathan, et al.
Publicado: (2020)

Association of plasma glial fibrillary acidic protein (GFAP) with neuroimaging of Alzheimer's disease and vascular pathology
por: Shir, Dror, et al.
Publicado: (2022)

Asymmetric Distribution of GFAP in Glioma Multipotent Cells
por: Guichet, Pierre-Olivier, et al.
Publicado: (2016)

Importance of GFAP isoform‐specific analyses in astrocytoma
por: van Bodegraven, Emma J., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4m7h1ppd853f62nktba528p1hr